What is Sana Biotechnology's G&A?

Sana Biotechnology (SANA) reported G&A of $11.46M in Q1 2026.

How has Sana Biotechnology's G&A changed year-over-year?

Sana Biotechnology's G&A decreased by 0.2% year-over-year, from $11.48M to $11.46M.

What is the long-term trend for Sana Biotechnology's G&A?

Over 4 years (2021 to 2025), Sana Biotechnology's G&A has grown at a -3.2% compound annual growth rate (CAGR), from $50.41M to $44.3M.

Overhead costs not directly tied to production or sales — corporate management, legal, accounting, office rent, insurance, and other administrative functions.

Sana Biotechnology SANA G&A

G&A at other companies

CRISPR TherapeuticsCRSP

$17.18M-11.0%

Cullinan Therapeutics, Inc.CGEM

$11.57M-14.5%

Intellia TherapeuticsNTLA

$34.84M+20.1%

Iovance Biotherapeutics, Inc.IOVA

$38.95M-11.1%

Beam TherapeuticsBEAM

$34.43M+23.2%

LeMaitre VascularLMAT

$12.05M+14.9%

Other financials

Income statement

See full

Operating income-$48.6M+4.0%

Net income-$47.2M+4.4%

EPS (diluted)-$0.17+19.0%

Balance sheet

See full

Cash & equivalents$83.8M-12.8%

Total debt$75.3M-17.5%

Total equity$119.2M-43.0%

Total assets$373.6M-16.1%

Cash flow

See full

Operating cash flow-$37.4M+23.2%

CapEx$288.0K+112%

Free cash flow-$37.7M+22.8%

Valuation

See full

Market cap$907.23M+54.1%

Enterprise value$898.76M+53.9%

Returns & leverage

See full

Return on equity-147.4%-2,468pp

Debt / equity0.6×+0.2×

Current ratio1.3×-2.1×

Where this comes from

Reported directly by Sana Biotechnology in its filing.

Tagged under the XBRL concept us-gaap:GeneralAndAdministrativeExpense.

The official record: Sana Biotechnology’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about Sana Biotechnology's g&a.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Sana Biotechnology's G&A?: Sana Biotechnology (SANA) reported G&A of $11.46M in Q1 2026.
How has Sana Biotechnology's G&A changed year-over-year?: Sana Biotechnology's G&A decreased by 0.2% year-over-year, from $11.48M to $11.46M.
What is the long-term trend for Sana Biotechnology's G&A?: Over 4 years (2021 to 2025), Sana Biotechnology's G&A has grown at a -3.2% compound annual growth rate (CAGR), from $50.41M to $44.3M.
What does G&A mean?: Overhead costs not directly tied to production or sales — corporate management, legal, accounting, office rent, insurance, and other administrative functions.